Nitin Lifesciences Ltd

What Nitin Lifesciences Ltd does

Nitin Lifesciences Ltd is an Indian pharmaceutical contract manufacturer founded in 1994 and headquartered in Haryana, specializing in small volume parenterals (injectables). The company operates three WHO-GMP certified manufacturing facilities located in Karnal (Haryana) and Paonta Sahib (Himachal Pradesh), with dedicated blocks for Beta Lactam, Cephalosporins and Lyophilized vials, and capabilities spanning liquid ampoules, liquid vials, dry powder vials (beta lactam, non-beta lactam, cephalosporins), lyophilized vials, and ophthalmic/otic drops. Facilities are maintained 24x7 per current cGMP standards and are designed to align with WHO Geneva, UK MHRA, EU GMP and US FDA expectations, with country-specific approvals in Kenya, Uganda and Nigeria. The product portfolio covers 200+ formulations across antibiotics, anti-malarials, NSAIDs, anti-inflammatory agents, local anesthetics, nutritional products, cardiac, dermatology and neuropsychiatry.

The business operates a sales-led, B2B contract manufacturing model serving leading Indian pharmaceutical companies and multinational corporations for both domestic and export markets, with exports reaching 11 countries via own registrations or third-party manufacturing arrangements. A separate branded distribution arm (PHARMA and NEWSURGE divisions) markets its own generics through 300+ distributors, 500 wholesalers and 40,000+ retail outlets, reaching over 100,000 doctors in India. The company is currently a wholly-owned subsidiary of Synokem Pharmaceuticals Ltd following a 2023 acquisition, having previously been majority-owned by Sweden-based Recipharm from 2016. It reports zero debt, 97% customer satisfaction, and approximately 450 employees across its manufacturing footprint.

Name

Nitin Lifesciences Ltd

Legal name

Nitin Lifesciences Ltd

Website

https://nitinlifesciences.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Nitin Lifesciences Ltd is an Indian pharmaceutical CDMO founded in 1994, specializing in contract manufacturing of small volume parenterals (injectables) across three WHO-GMP plants for Indian pharma companies, MNCs and exports to 11 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

akta.pro secondary industries

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH), Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

Keywords

• Contract pharmaceutical manufacturing
• Injectable manufacturing services
• Small volume parenterals
• Lyophilized injectables
• Cephalosporin injections

Headquarters

HQ city

Haryana

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Contract Manufacturing Services: Contract manufacturing services for pharmaceutical companies for both domestic and export markets. Specializes in small volume parenterals including liquid vials, dry vials, lyophilized vials, and eye/ear drops.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Nitin Lifesciences Ltd is an Indian pharmaceutical contract manufacturer specializing in small volume parenterals (injectables). It produces liquid ampoules, liquid vials, dry powder vials (beta lactam and non-beta lactam), lyophilized vials, and eye/ear drops across three WHO-GMP certified facilities in India. The company operates a B2B contract manufacturing model serving pharmaceutical companies in India and 11 export markets.

Product overview

Nitin Lifesciences Ltd is a pharmaceutical company specializing in small volume parenteral (injectable) manufacturing. The company's core product portfolio consists of five main categories: General Injectables (liquid injections), Cephalosporins Injections, Beta Lactams Injections, Lyophilized Injectables, and Ophthalmics (Eye & Ear Drops). These products are manufactured across three WHO-GMP certified facilities in Karnal, Haryana and Paonta Sahib, Himachal Pradesh. The company offers contract manufacturing services for domestic and international pharmaceutical companies, producing over 200 formulations including liquid vials, dry vials (non-beta lactam, beta lactam, and cephalosporins), liquid ampoules, lyophilized vials, and eye/ear drops. The manufacturing capabilities span multiple therapeutic areas including antibiotics, anti-malarials, NSAIDs, anti-inflammatory, local anesthetics, nutritional products, cardiac care, and dermatology.

Differentiator

Problem solved

Functional benefit

Brands

• PHARMA Division: Handles brands such as Nitzole, Nitzole-D, Necob, Necob Plus, Nitaxim, Nefzon, Nitizest, N-Zol, Nicin, Neodec, Nandro, Nitipime, Nether, Niclospas. Handles Cephalosporins, Antibacterials, Antimalarials, NSAIDs and Cough preparations.
• NEWSURGE Division

Products and services

• General Injectables (Liquid Injections)

Quantifiable outcome

• 97% customer satisfaction rate
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Centrient Pharmaceuticals: Netherlands-headquartered producer of beta-lactam APIs and sterile injectable finished dosage forms, with manufacturing in the Netherlands and India. Comparable on beta-lactam injectable manufacturing and pharmaceutical CDMO services, though it is primarily an API-forward business.

Broad incumbents

• Baxter BioPharma Solutions: Global sterile injectable contract manufacturing and packaging business, including lyophilized vials, prefilled syringes and liquid vials for pharma partners. Comparable on injectable CMO services and lyophilization, but operates at much larger scale and is focused on regulated-market clients.
• Wockhardt Ltd: India-based pharmaceutical company with a large sterile injectables (lyophilized, liquid vials) and beta-lactam/cephalosporin manufacturing base serving regulated and emerging markets. Comparable on injectable portfolio and cephalosporin capabilities, though it also markets branded generics globally.
• Piramal Pharma Solutions: Large Indian CDMO platform offering sterile injectables, oral solids and API services with global facilities. Overlaps with Nitin on injectable contract manufacturing and lyophilization, but operates at significantly greater scale and breadth.
• Aurobindo Pharma Ltd: Large Indian generic manufacturer with substantial sterile injectable capacity and a growing CDMO business supplying global pharma. Comparable on injectable manufacturing scale and cephalosporin/beta-lactam capabilities, though diversified across multiple dosage forms.
• Recipharm AB: Swedish-headquartered global CDMO covering sterile injectables, biologics and oral dosage forms; former majority owner of Nitin Lifesciences (2016–2023). Comparable on injectable CDMO capabilities, though significantly larger and more diversified across geographies and dosage forms.

Direct peers

• Maiva Pharma Pvt Ltd: India-based injectable-focused CDMO with sterile manufacturing for liquid vials, lyophilized injectables and prefilled syringes, serving global generic and innovator pharma. Comparable in scale and product mix to Nitin Lifesciences' injectable franchise.
• Gland Pharma Ltd: India-listed pure-play sterile injectables manufacturer and CDMO with strong US FDA footprint, serving global pharma companies. Direct comparable on small/large volume parenterals, lyophilized injectables, and contract manufacturing for innovators and generics.
• Synokem Pharmaceuticals Ltd: Parent company of Nitin Lifesciences and itself one of the largest CDMOs in India, focused on finished dosage formulations including injectables. Directly comparable on injectable CDMO services, Indian manufacturing footprint and customer base of pharma clients.
• Aizant Drug Solutions: India-based CDMO specialising in sterile liquid parenterals, ophthalmics and lyophilized injectables, supplying global pharma. Closely comparable on aseptic injectable manufacturing, lyophilization capabilities and B2B contract manufacturing model.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights6 records

Customer concentration

• Xtwitter.com/NitinLtd
• YouTubeyoutube.com/watch?v=aawpW83PDgQ
• Facebookfacebook.com/NITINLIFESCIENCESLIMITED
• LinkedInlinkedin.com/company/nitin-lifesciences-ltd-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nitin Lifesciences Ltd